Source: CME Group
USD Malaysian Crude Palm Oil volume and open interest
In October 2021, CME Crude Palm Oil volume totaled 26,854 lots (671,350 metric tons) and the end-of-month open interest was 43,772 lots (1,094,300 metric tons). Volume and end-of-month OI in the first three contract months were 7,794 and 20,908, respectively.
USD Malaysian Crude Palm Oil Calendar futures (CPO) performance:
- Total volume: 23,014 lots. Volume in the first three contract months: 4,374 lots (dotted bars in the chart).
- Total end-of-month OI: 25,922 lots. Open interest in the first three contract months: 4,508 lots.
Malaysian Palm Oil Calendar swaps (CPC) performance:
- Total volume: 3,840 lots. Volume in the first three contract months: 3,420 lots (dotted bars in the chart).
- Total end-of-month OI: 17,850 lots. Open interest in the first three contract months: 16,400 lots.
Source: CME Group
Source: CME Group
USD Malaysian Crude Palm Oil price and volatility
USD Malaysian Crude Palm Oil futures* settled at $1,193.25 per metric ton at the end of October 2021, creating a $150.50 price movement from the beginning of the month.
During the month, 20-day rolling volatility ranged from 33.1% to 36.7%, with an average of 34.6%.
Source: CME Group
Bean Oil – Palm Oil spread, Palm Oil – Gasoil spread price and Palm Oil FOB Indonesia basis price
Bean Oil – Palm Oil (BOPO)** price decreased from $249.38 per ton at the beginning of the month, to $157.52 per ton at the end of the month. The monthly movement was -$91.86.
Source: CME Group
Palm Oil – Gasoil (POGO)*** increased from $369.50 per ton at the beginning of the month, to $474.75 per ton at the end of the month. The monthly movement was $105.25.
Source: CME Group
The FOB Indonesia Basis****, the price spread between Indonesian and Malaysian crude oil palm, increased from $132.25 per ton at the beginning of the month, to $121.75 per ton at the end of the month. The monthly movement was -$10.50.
Source: CME Group
Get the latest highlights for Malaysian Crude Palm Oil futures and swaps at CME Group.
The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. The content was purely for informational purposes only and not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.